FIELD: medicine.
SUBSTANCE: invention represents a method for the prediction of preeclampsia in the second trimester of pregnancy by blood examination, differing by the fact that the activity of acid and neutral proteinases is measured in blood serum of the women 7-8 weeks pregnant; if the activity of acid proteinases is more than 5.6 mcmole/l, while the activity of neutral proteinases is more than 3.9 mcmole/l, the preeclampsia progression in the second trimester of pregnancy is predicted.
EFFECT: higher accuracy and specificity of the method for the prediction of gestational toxicosis.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PREECLAMPSIA IN PREGNANT WOMEN WITH GESTATIONAL DIABETES MELLITUS | 2020 |
|
RU2740852C1 |
| METHOD FOR PREDICTION OF SEVERE PREECLAMPSIA IN PREGNANT WOMEN ACCOMPANYING A MUTATION OF THE PROTHROMBIN GENE, GENOTYPE F2G20210A | 2019 |
|
RU2723627C1 |
| METHOD FOR PREECLAMPSIA PREDICTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 GENE OF G/A AND A/A GENOTYPE | 2016 |
|
RU2636228C1 |
| METHOD FOR FORECASTING DEVELOPMENT OF PRE-ECLAMPSIA IN LATE PREGNANCY | 2018 |
|
RU2691114C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD FOR EARLY PREDICTION OF FETAL GROWTH RETARDATION | 2019 |
|
RU2718725C1 |
| METHOD FOR PREDICTION OF ONSET OF GESTOSIS IN PREGNANT WOMEN | 2011 |
|
RU2478960C2 |
| METHOD OF EARLY PREDICTION OF PREECLAMPSIA PROGRESSION | 2016 |
|
RU2648872C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA | 2023 |
|
RU2817206C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF PRE-ECLAMPSIA IN WOMEN OF DIFFERENT SOMATOTYPES | 2018 |
|
RU2679111C1 |
